Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 256

Similar articles for PubMed (Select 17872942)

1.

Effects of body mass index and age on N-terminal pro brain natriuretic peptide are associated with glomerular filtration rate in chronic heart failure patients.

Schou M, Gustafsson F, Kistorp CN, Corell P, Kjaer A, Hildebrandt PR.

Clin Chem. 2007 Nov;53(11):1928-35. Epub 2007 Sep 14.

2.

Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.

Anwaruddin S, Lloyd-Jones DM, Baggish A, Chen A, Krauser D, Tung R, Chae C, Januzzi JL Jr.

J Am Coll Cardiol. 2006 Jan 3;47(1):91-7. Epub 2005 Dec 9.

3.

Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure.

Kistorp C, Faber J, Galatius S, Gustafsson F, Frystyk J, Flyvbjerg A, Hildebrandt P.

Circulation. 2005 Sep 20;112(12):1756-62. Epub 2005 Sep 12.

4.

N-terminal pro-brain natriuretic peptide, kidney disease and outcome in patients with chronic heart failure.

Bruch C, Reinecke H, Stypmann J, Rothenburger M, Schmid C, Breithardt G, Wichter T, Gradaus R.

J Heart Lung Transplant. 2006 Sep;25(9):1135-41. Epub 2006 Aug 2.

PMID:
16962477
5.

Urinary N-terminal prohormone brain natriuretic peptide excretion in patients with chronic heart failure.

Linssen GC, Damman K, Hillege HL, Navis G, van Veldhuisen DJ, Voors AA.

Circulation. 2009 Jul 7;120(1):35-41. doi: 10.1161/CIRCULATIONAHA.108.824581. Epub 2009 Jun 22.

6.

Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.

Krauser DG, Lloyd-Jones DM, Chae CU, Cameron R, Anwaruddin S, Baggish AL, Chen A, Tung R, Januzzi JL Jr.

Am Heart J. 2005 Apr;149(4):744-50.

PMID:
15990762
7.

B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy.

Vickery S, Price CP, John RI, Abbas NA, Webb MC, Kempson ME, Lamb EJ.

Am J Kidney Dis. 2005 Oct;46(4):610-20.

PMID:
16183415
8.

Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.

von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.

J Am Coll Cardiol. 2007 Nov 13;50(20):1973-80. Epub 2007 Oct 29.

9.
10.
11.

Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea.

Bayes-Genis A, Lloyd-Jones DM, van Kimmenade RR, Lainchbury JG, Richards AM, Ordoñez-Llanos J, Santaló M, Pinto YM, Januzzi JL Jr.

Arch Intern Med. 2007 Feb 26;167(4):400-7.

PMID:
17325303
12.

Role of N-terminal pro-brain natriuretic peptide and cystatin C to estimate renal function in patients with and without heart failure.

Linzbach S, Samigullin A, Yilmaz S, Tsioga M, Zeiher AM, Spyridopoulos I.

Am J Cardiol. 2009 Apr 15;103(8):1128-33. doi: 10.1016/j.amjcard.2009.01.009. Epub 2009 Mar 4.

PMID:
19361601
13.

Relationship between N-terminal pro-B-type natriuretic peptide plasma levels and renal function evaluated with different formulae in older adult subjects admitted because of dyspnea.

Fabbian F, De Giorgi A, Portaluppi F, Zuliani G.

Gerontology. 2012;58(1):50-5. doi: 10.1159/000326243. Epub 2011 Apr 29.

PMID:
21540563
14.

Direct comparison of transcardiac increase in brain natriuretic peptide (BNP) and N-terminal proBNP and prognosis in patients with chronic heart failure.

Tsutamoto T, Sakai H, Nishiyama K, Tanaka T, Fujii M, Yamamoto T, Horie M.

Circ J. 2007 Dec;71(12):1873-8.

15.

Differential associations between renal function and "modifiable" risk factors in patients with chronic heart failure.

Smilde TD, Damman K, van der Harst P, Navis G, Westenbrink BD, Voors AA, Boomsma F, van Veldhuisen DJ, Hillege HL.

Clin Res Cardiol. 2009 Feb;98(2):121-9. doi: 10.1007/s00392-008-0732-z. Epub 2008 Oct 31.

PMID:
18979056
16.

[Obesity as a risk factor of chronic kidney disease in patients undergoing primary angioplasty].

Bachórzewska-Gajewska H, Małyszko J, Małyszko J, Poniatowski B, Musiał W, Dobrzycki S, Kinalska I.

Pol Arch Med Wewn. 2006 Oct;116(4):916-23. Polish.

PMID:
18416292
17.

Left ventricular cavity area reflects N-terminal pro-brain natriuretic peptide plasma levels in heart failure.

Taléns-Visconti R, Rivera Otero M, Sancho-Tello MJ, de Burgos FG, Martínez-Dolz L, Sevilla B, Climent V, Cortés R, Salvador A, Sogorb F, Miro V, Valero R, Perez-Boscá JL, Bertomeu V, Portolés M, Payá R.

Eur J Echocardiogr. 2006 Jan;7(1):45-52. Epub 2005 Jun 4.

18.

Correlates of NT-proBNP concentration in patients with essential hypertension in absence of congestive heart failure.

Toda K, Sato Y, Hara T, Hijiya K, Kaneko R, Okada T, Takatsu Y, Fujiwara H, Iwasaki T.

J Clin Lab Anal. 2010;24(1):12-6. doi: 10.1002/jcla.20366.

PMID:
20087954
19.

Relation of N-terminal pro-brain natriuretic peptide levels and their prognostic power in chronic stable heart failure to obesity status.

Frankenstein L, Remppis A, Nelles M, Schaelling B, Schellberg D, Katus H, Zugck C.

Eur Heart J. 2008 Nov;29(21):2634-40. doi: 10.1093/eurheartj/ehn388. Epub 2008 Sep 2.

20.

N-terminal pro-B-type natriuretic peptide level is depressed in patients with significant coronary artery disease who have high body mass index.

Hong SN, Ahn Y, Yoon NS, Moon JY, Kim KH, Hong YJ, Park HW, Kim JH, Jeong MH, Cho JG, Park JC, Kang JC.

Int Heart J. 2008 Jul;49(4):403-12.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk